---
figid: PMC3536347__cshperspect-WNT-008086_F1
figlink: /pmc/articles/PMC3536347/figure/A008086F1/
number: F1
caption: Pharmacologic inhibitors of the Wnt/β-catenin signaling pathway and known
  interactions with pathway components (see  for references). This figure depicts
  the Wnt/β-catenin pathway in its active state, with cytoplasmic accumulation and
  nuclear translocation of β-catenin, along with the transactivation of target genes
  in the nucleus mediated by interaction between β-catenin and members of the TCF
  family of transcription factors. Note that in contexts in which downstream mutations
  in APC or β-catenin result in constitutive pathway activation, the use of upstream
  inhibitors that target ligand secretion, ligand binding, and even the APC-AXIN-GSK3β
  complex may not be sufficient to inhibit signaling. Also, targeting of β-catenin
  interactors can involve either the disruption of protein interactions or the direct
  inhibition of transcriptional activity (see also  for additional details and references).
pmcid: PMC3536347
papertitle: Targeting Wnt Pathways in Disease.
reftext: Zachary F. Zimmerman, et al. Cold Spring Harb Perspect Biol. 2012 Nov;4(11):a008086.
pmc_ranked_result_index: '14453'
pathway_score: 0.9469305
filename: cshperspect-WNT-008086_F1.jpg
figtitle: Pharmacologic inhibitors of the Wnt/Beta-catenin signaling pathway and known
  interactions with pathway components (see  for references)
year: '2012'
organisms:
- Homo sapiens
ndex: b64c2a50-deab-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3536347__cshperspect-WNT-008086_F1.html
  '@type': Dataset
  description: Pharmacologic inhibitors of the Wnt/β-catenin signaling pathway and
    known interactions with pathway components (see  for references). This figure
    depicts the Wnt/β-catenin pathway in its active state, with cytoplasmic accumulation
    and nuclear translocation of β-catenin, along with the transactivation of target
    genes in the nucleus mediated by interaction between β-catenin and members of
    the TCF family of transcription factors. Note that in contexts in which downstream
    mutations in APC or β-catenin result in constitutive pathway activation, the use
    of upstream inhibitors that target ligand secretion, ligand binding, and even
    the APC-AXIN-GSK3β complex may not be sufficient to inhibit signaling. Also, targeting
    of β-catenin interactors can involve either the disruption of protein interactions
    or the direct inhibition of transcriptional activity (see also  for additional
    details and references).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD2
  - FZD5
  - FZD3
  - DVL2
  - FZD7
  - WNT7A
  - FZD10
  - WNT8A
  - DVL1
  - WNT2
  - WNT7B
  - DVL3
  - GSK3B
  - FZD9
  - WNT3
  - FZD8
  - WNT6
  - WNT8B
  - CRX
  - WNT5A
  - WNT4
  - WNT1
  - WNT16
  - KRT10
  - TNKS
  - WNT10B
  - FZD1
  - LRP5
  - FZD6
  - WNT9A
  - WNT3A
  - CTNNB1
  - WNT9B
  - FZD4
  - SFRP4
  - WNT5B
  - APC
  - WNT11
  - WNT2B
  - WNT10A
  - LRP6
  - Pyrvinium
  - CGP049090
  - Retinoids
genes:
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: FZD7
  symbol: FZD7
  source: hgnc_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: FZD8
  symbol: FZD8
  source: hgnc_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: CRD
  symbol: CRD
  source: hgnc_alias_symbol
  hgnc_symbol: CRX
  entrez: '1406'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: CK10
  symbol: CK10
  source: hgnc_alias_symbol
  hgnc_symbol: KRT10
  entrez: '3858'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: TNKS
  symbol: TNKS
  source: hgnc_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: SFRP4
  symbol: SFRP4
  source: hgnc_symbol
  hgnc_symbol: SFRP4
  entrez: '6424'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
chemicals:
- word: Pyrvinium
  source: MESH
  identifier: C024631
- word: CGP049090
  source: MESH
  identifier: C538948
- word: Retinoids
  source: MESH
  identifier: D012176
diseases: []
figid_alias: PMC3536347__F1
redirect_from: /figures/PMC3536347__F1
figtype: Figure
---
